283 related articles for article (PubMed ID: 20237941)
1. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
2. Detection and identification of potential biomarkers of non-small cell lung cancer.
Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
[TBL] [Abstract][Full Text] [Related]
3. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
[TBL] [Abstract][Full Text] [Related]
4. Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.
Miguet L; Bogumil R; Decloquement P; Herbrecht R; Potier N; Mauvieux L; Van Dorsselaer A
J Proteome Res; 2006 Sep; 5(9):2258-69. PubMed ID: 16944938
[TBL] [Abstract][Full Text] [Related]
5. Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia.
Shi L; Zhang J; Wu P; Feng K; Li J; Xie Z; Xue P; Cai T; Cui Z; Chen X; Hou J; Zhang J; Yang F
Proteome Sci; 2009 Mar; 7():7. PubMed ID: 19291297
[TBL] [Abstract][Full Text] [Related]
6. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
7. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
[TBL] [Abstract][Full Text] [Related]
9. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay.
Song Z; Dong R; Fan Y; Zheng S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):370-5. PubMed ID: 22569524
[TBL] [Abstract][Full Text] [Related]
12. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
13. Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry.
Chen J; Anderson M; Misek DE; Simeone DM; Lubman DM
J Chromatogr A; 2007 Aug; 1162(2):117-25. PubMed ID: 17434173
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
Malik G; Ward MD; Gupta SK; Trosset MW; Grizzle WE; Adam BL; Diaz JI; Semmes OJ
Clin Cancer Res; 2005 Feb; 11(3):1073-85. PubMed ID: 15709174
[TBL] [Abstract][Full Text] [Related]
15. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.
Cheng L; Zhou L; Tao L; Zhang M; Cui J; Li Y
J Cancer Res Clin Oncol; 2008 Jul; 134(7):769-76. PubMed ID: 18202856
[TBL] [Abstract][Full Text] [Related]
16. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.
Kurono S; Kaneko Y; Matsuura N; Oishi H; Noguchi S; Kim SJ; Tamaki Y; Aikawa T; Kotsuma Y; Inaji H; Matsuura S
Proteomics Clin Appl; 2016 May; 10(5):605-13. PubMed ID: 26970563
[TBL] [Abstract][Full Text] [Related]
18. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
19. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]